Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.
Banner Image

HON 499: Spring 2017 Professor Moon's Library Instruction (Dr. Duncan): SH


Cite as you write

Generate citations and bibliographies in a whole range of journal styles with just a few clicks. For your convenience, we've made sure Mendeley's Citation Plugin is fully compatible with Word (including Word for Mac)....

e-articles in Science Direct

Exploring the potential of genome editing CRISPR-Cas9 technology

  • a Institute of Systems and Synthetic Biology, Genopole, CNRS, UEVE, Université Paris-Saclay, 5 rue Henri Desbruères, 91030 Évry, France
  • b Chemical and Synthetic Biology Group, School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India


Efficient Gene Editing in Primary Human T Cells

Author: Yvonne Y Chen Affiliation: Department of Chemical and Biomolecular Engineering, University of California—Los Angeles, Los Angeles, CA 90095, USA
Edition/Format: Article Article : English
Publication: Trends in Immunology, v36 n11 (201511): 667-669
Database: Copyright 2017 Elsevier B.V. All rights reserved
Recent advances in T-cell therapy for cancer, viral infections, and autoimmune diseases highlight the broad therapeutic potential of T-cell engineering. However, site-specific genetic manipulation in primary human T cells remains challenging. Two recent studies describe efficient genome editing in T cells using CRISPR and TALEN approaches.


Self-targeting by CRISPR: gene regulation or autoimmunity?

Author: A Stern Affiliation: Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.; L Keren; O Wurtzel; G Amitai; R Sorek
Edition/Format: Article Article : English
Publication: Trends in genetics : TIG, 2010 Aug; 26(8): 335-40
Database: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Other Databases: ArticleFirstWorldCatBritish Library Serials
The recently discovered prokaryotic immune system known as CRISPR (clustered regularly interspaced short palindromic repeats) is based on small RNAs ('spacers') that restrict phage and plasmid infection. It has been hypothesized that CRISPRs can also regulate self gene expression by utilizing spacers that target self genes. By analyzing CRISPRs from 330 organisms we found that one in every 250 spacers is self-targeting, and that such self-targeting occurs in 18% of all CRISPR-bearing organisms. However, complete lack of conservation across species, combined with abundance of degraded repeats near self-targeting spacers, suggests that self-targeting is a form of autoimmunity rather than a regulatory mechanism. We propose that accidental incorporation of self nucleic acids by CRISPR can incur an autoimmune fitness cost, and this could explain the abundance of degraded CRISPR systems across prokaryotes.